Respiratory Medicine
Volume 104, Issue 3 , Pages 378-388 , March 2010

Mass of intercostal muscles associates with risk of multiple exacerbations in COPD

  • Roberto Güerri

      Affiliations

    • Servei de Medicina Interna, Hospital del Mar, Barcelona, Spain
    • ,
  • Angel Gayete

      Affiliations

    • Servei de Pneumologia, Hospital del Mar, Barcelona, Spain
    • ,
  • Eva Balcells

      Affiliations

    • Servei de Pneumologia, Hospital del Mar, Barcelona, Spain
    • ,
  • Alba Ramirez-Sarmiento

      Affiliations

    • Servei de Pneumologia, Hospital del Mar, Barcelona, Spain
    • Grup de Recerca en Lesió, Resposta Immune i Funció Pulmonar (LIF), Institut Municipal d'Investigació Mèdica (IMIM), CEXS-Universitat Pompeu Fabra, Barcelona, Spain
    • CIBER de Enfermedades Respiratorias (CibeRes), ISCIII, Ministerio de Ciencia y Tecnología, Spain
    • ,
  • Ivan Vollmer

      Affiliations

    • Servei de Radiodiagnostic CRC-Mar, Barcelona, Spain
    • ,
  • Judith Garcia-Aymerich

      Affiliations

    • Centre for Research in Environmental Epidemiology (CREAL), Institut Municipal d'Investigació Mèdica (IMIM-Hospital del Mar), Department of Experimental and Health Sciences, Universitat Pompeu Fabra, CIBER Epidemiologia y Salud Pública (CIBERESP), Barcelona, Spain
    • ,
  • Joaquim Gea

      Affiliations

    • Servei de Pneumologia, Hospital del Mar, Barcelona, Spain
    • Grup de Recerca en Lesió, Resposta Immune i Funció Pulmonar (LIF), Institut Municipal d'Investigació Mèdica (IMIM), CEXS-Universitat Pompeu Fabra, Barcelona, Spain
    • CIBER de Enfermedades Respiratorias (CibeRes), ISCIII, Ministerio de Ciencia y Tecnología, Spain
    • ,
  • Mauricio Orozco-Levi

      Affiliations

    • Servei de Pneumologia, Hospital del Mar, Barcelona, Spain
    • Grup de Recerca en Lesió, Resposta Immune i Funció Pulmonar (LIF), Institut Municipal d'Investigació Mèdica (IMIM), CEXS-Universitat Pompeu Fabra, Barcelona, Spain
    • CIBER de Enfermedades Respiratorias (CibeRes), ISCIII, Ministerio de Ciencia y Tecnología, Spain
    • Corresponding Author InformationCorresponding author. Servei de Pneumologia, Hospital del Mar, Passeig Marítim 25, E-08003 Barcelona, Spain. Fax: +34 93 221 3237.

Received 22 June 2009 ,Accepted 19 October 2009.

References 

  1. Global Initiative for Chronic Obstructive Lung Disease (GOLD) . Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. NHLBI/WHO workshop report. Bethesda, MD: National Heart, Lung, and Blood Institute; 2001;[NIH publication no. 2701]
  2. Murray CJL, Lopez AD. Mortality by cause for eight regions of the world: global burden of disease study. Lancet. 1997;349:1269–1276
  3. Okubadejo AA, Jones PW, Wedzicha JA. Quality of life in patients with chronic obstructive pulmonary disease and severe hypoxaemia. Thorax. 1996;51:44–47
  4. Peña VS, Miravitlles M, Gabriel R, et al. Geographic variations in prevalence and underdiagnosis of COPD. Results of the IBERCOP multicentre epidemiological study. Chest. 2000;118:981–989
  5. Connolly MJ, Lowe D, Anstey K, et al. Admissions to hospital with exacerbations of chronic obstructive pulmonary disease: effect of age related factors and service organisation. Thorax. 2006;61:843–848
  6. Soler-Cataluna JJ, Martinez-Garcia MA, Roman Sanchez P, et al. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005;60:925–931
  7. Newman AB, Haggerty CL, Goodpaster B, et al. Strength and muscle quality in a cohort of well-functioning older adults: the health, aging and body composition study. J Am Geriatr Soc. 2003;51:323–330
  8. Metier EJ, Lynch N, Conwit R, et al. Muscle quality and age: cross-sectional and longitudinal comparisons. J Gerontol Biol Sci Med Sci. 1999;54A:B207–B218
  9. Baumgartner RN. Body composition in healthy aging. Ann N Y Acad Sci. 2000;904:437–448
  10. Gallagher D, Visser M, De Meersman RE, Sepúlveda D, Baumgartner RN, Pierson RN, et al. Appendicular skeletal mass: effects of age, gender, and ethnicity. J Appl Physiol. 1997;83:229–239
  11. Evans W. Functional and metabolic consequences of sarcopenia. J Nutr. 1997;127:9985–10035
  12. Visser M, Deeg DJ, Lips P, et al. Skeletal muscle mass and muscle strength in relation to lower-extremity performance in older men and women. J Am Geriatr Soc. 2000;48:381–386
  13. Orozco-Levi M. Structure and function of respiratory muscles in patients with COPD: impairment or adaptation?. Eur Respir J. 2003;46:41s–51s
  14. Parker CM, Voduc N, Aaron SD, et al. Physiological changes during symptom recovery from moderate exacerbations of COPD. Eur Respir J. 2005;26:420–428
  15. Garcia-Aymerich J, Farrero E, Félez MA, et al. Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. Thorax. 2003;58:100–105
  16. World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. Adopted by the 18th WMA General Assembly Helsinki, Finland, June 1964 and amended by the 52nd WMA General Assembly, Edinburgh, Scotland. http://ohsr.od.nih.gov/guidelines/helsinki.htmlOctober 2000;Accessible online at
  17. Ramírez-Sarmiento A, Orozco-Levi M, Güell R, et al. Inspiratory muscle training in patients with chronic obstructive pulmonary disease: structural adaptation and physiologic outcomes. Am J Respir Crit Care Med. 2002;166:1491–1497
  18. Celli BR, MacNee W and committee members. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23:932–946
  19. Siafakas NM, Vermeire P, Pride NB, et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur Respir J. 1995;8:1398–1420
  20. Barbera JA, Peces-Barba G, Agusti AGN, et al. Clinical guidelines for the diagnosis and treatment of chronic obstructive pulmonary disease. Arch Bronconeumol. 2001;37:297–316
  21. American Thoracic Society . Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1995;152:S77–S121
  22. Caskey CI, Zerhouni EA, Fishman EK, et al. Aging of the diaphragm: a CT study. Radiology. 1989;171:385–389
  23. Larsson L, Grimby G, Karlsson J. Muscle strength and speed of movement in relation to age and muscle morphology. J Appl Physiol Respir Environ Exercise Physiol. 1979;46:451–456
  24. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987;40:373–383
  25. Orozco-Levi M, Lloreta J, Minguella , et al. Injury of the human diaphragm associated with exertion and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;164:1734–1739
  26. Kelley DE, Slasky BS, Janosky J. Skeletal muscle density: effects of obesity and non-insulin-dependent diabetes mellitus. Am J Clin Nutr. 1991;54:509–515
  27. Schelesselman J. Case-control studies: design, conduct and analysis. New York: Oxford University Press; 1982;
  28. Agusti AG, Noguera A, Sauleda J, et al. Systemic effects of chronic obstructive pulmonary disease. Eur Respir J. 2003;21:347–360
  29. Landbo C, Prescott E, Lange P, et al. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;160:1856–1861
  30. Gray-Donald K, Gibbons L, Shapiro SH, et al. Nutritional status and mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1996;153:961–966
  31. Schols AM, Slangen J, Volovics L, et al. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157:1791–1797
  32. Prescott E, Almdal T, Mikkelsen KL, et al. Prognostic value of weight change in chronic obstructive pulmonary disease: results from the Copenhagen City Heart Study. Eur Respir J. 2002;20:539–544
  33. Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350:1005–1012
  34. Engelen MP, Schols AM, Baken WC, et al. Nutritional depletion in relation to respiratory and peripheral skeletal muscle function in an outpatient population with chronic obstructive pulmonary disease. Eur Respir J. 1994;7:1793–1797
  35. Nishimura Y, Tsutsumi M, Nakata H, et al. Relationship between respiratory muscle strength and lean body mass in men with COPD. Chest. 1995;107:1232–1236
  36. Heymsfield SB, Williams PJ. Nutritional assessment by clinical and biochemical methods. In:  Shils ME,  Olson JA editor. Modern nutrition in health and disease. Philadelphia: Lea & Febiger; 1994;p. 812–841
  37. Bernard S, Leblanc P, Whittom F, et al. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;158:629–634
  38. Marquis K, Debigaré R, Lacasse Y, et al. Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2002;166:809–813
  39. Soler-Cataluna JJ, Sanchez-Sanchez L, Martinez-Garcia MA, et al. Mid-arm muscle area is a better predictor of mortality than body mass index in COPD. Chest. 2005;128:2108–2115
  40. Coronell C, Orozco-Levi M, Méndez R, Ramírez-Sarmiento A, Gáldiz JB, Gea J. Relevance of assessing quadriceps endurance in patients with COPD. Eur Respir J. 2004;24:129–136
  41. Orozco-Levi M, Gea J, Lloreta J, et al. Subcellular adaptation of the human diaphragm in chronic obstructive pulmonary disease. Eur Respir J. 1999;13:371–378
  42. Vitacca M, Bianchi L, Barbano L, et al. Lung and respiratory muscle function at discharge from a respiratory intensive care unit. Monaldi Arch Chest Dis. 2005;63:142–148
  43. Wouters EFM. Chronic obstructive pulmonary disease 5: systemic effects of COPD. Thorax. 2002;57:1067–1070
  44. Congleton J. The pulmonary cachexia syndrome: aspects of energy balance. Proc Nutr Soc. 1999;58:321–328
  45. Schols AM, Mostert R, Soeters PB, et al. Body composition and exercise performance in patients with chronic obstructive pulmonary disease. Thorax. 1991;46:695–699
  46. Vermeeren MAP, Schols AMWJ, Wouters EFM. Effects of an acute exacerbation on nutritional and metabolic profile of patients with COPD. Eur Respir J. 1997;10:2264–2269
  47. Anonymous . Skeletal muscle dysfunction in chronic obstructive pulmonary disease. A statement of the American Thoracic Society and European Respiratory Society. Am J Respir Crit Care Med. 1999;159:S1–S40
  48. Orozco-Levi M, Lloreta J, Gea J. The “oil-well analogy” as a comprehensive interpretation of factors leading to muscle injury and wasting. Ultrastruct Pathol. 2006;30:247–252

PII: S0954-6111(09)00348-5

doi: 10.1016/j.rmed.2009.10.015

Respiratory Medicine
Volume 104, Issue 3 , Pages 378-388 , March 2010

Article Tools

* Image Usage & Resolution